COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

HistoSonics-CSP1427-HOPE4LIVER: The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER US)

Protocol No
HISTOSONICS-CSP1427-HOPE4LIVER
Principal Investigator
Sarah White
Phase
N/A
Summary
The purpose of this study is to evaluate how well the HistoSonics Histotripsy System works for treatment of liver tumors. This study involves research. The clinical study that we are presenting to you here is - as required by law - approved by the US Food and Drug Administration (FDA) and the Institutional Review Board (IRB) at this study site in order to collect information to assess if this treatment is safe and effective and may provide potential benefits. The HistoSonics Histotripsy System is investigational, which means that it is not approved by the FDA to be sold in the United States. We don't know if this study will help you. Your condition may get better, but it could stay the same or even get worse. We hope the information from this study will help us develop a better treatment for liver cancer in the future.
Description
HistoSonics System for Treatment of Primary & Metastatic Liver Tumors Using Histotripsy #HOPE4LIVER
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL